, Tracking Stock Market Picks
Enter Symbol:
Aegerion Pharmaceuticals, Inc. (AEGR) [hlAlert]

down 76.74 %

Aegerion Pharmaceuticals, Inc. (AEGR) downgraded to Hold with price target $26 by Deutsche Bank

Posted on: Friday,  Oct 31, 2014  1:25 PM ET by Deutsche Bank

Deutsche Bank rated Hold Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR) on 10/31/2014. Previously Deutsche Bank rated Buy Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR) on
11/13/2013., when the stock price was $82.81. Since then, Aegerion Pharmaceuticals, Inc. has lost 76.74% as of 10/31/2014's recent price of $19.26.
If you would have followed the previous Deutsche Bank's recommendation on AEGR, you would have lost 76.74% of your investment in 352 days.

Aegerion Pharmaceuticals, Inc. (Aegerion) is a biopharmaceutical company focused on the development and commercialization of therapeutics to treat severe lipid disorders. Its lead compound, lomitapide, is a microsomal triglyceride transfer protein inhibitor (MTP-I), which limits secretion of cholesterol and triglycerides from the intestines and the liver, the main sources of lipids in the body. The Company is initially developing lomitapide as an oral, once-a-day treatment for patients with a rare genetic lipid disorder called homozygous familial hypercholesterolemia (HoFH). HoFH is a genetic lipid disorder caused by defects in both copies of the low-density lipoprotein (LDL) receptor genes, resulting in impaired or total loss of function in the LDL receptor.

Deutsche Bank is one of the largest European fund managers. DWS was founded in 1956 and is an integral part of the Asset Management division of Deutsche Bank. This division is one of the largest global asset managers.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/31/2014 1:25 PM Hold
19.26 26.00
as of 10/17/2014
1 Week up  4.97 %
1 Month down  -7.95 %
3 Months up  13.05 %
1 YTD down  -56.29 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/13/2013 2:25 PM Buy
82.81 115.00
11/9/2011 1:25 PM Buy
14.76 19.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy